Similar articles

• Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions.

  Karges B, Kapellen T, Neu A, Hofer SE, Rohrer T, Rosenbauer J, Wolf J, Holl RW; Diabetes Prospective Documentation DPV Initiative; German Federal Ministry for Education and Research BMBF Competence Network of Diabetes Mellitus. Karges B, et al. Diabetes Care. 2010 May;33(5):1031-3. doi: 10.2337/dc09-2249. Epub 2010 Feb 25. Diabetes Care. 2010. PMID: 20185733 Free PMC article.
• Pediatric diabetic ketoacidosis: an outpatient perspective on evaluation and management.

  Bonadio W. Bonadio W. Pediatr Emerg Med Pract. 2013 Mar;10(3):1-13; quiz 14. Pediatr Emerg Med Pract. 2013. PMID: 23971271 Review.
• Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.

  Wahid M, Naveed AK, Hussain I. Wahid M, et al. J Coll Physicians Surg Pak. 2006 Jan;16(1):11-4. J Coll Physicians Surg Pak. 2006. PMID: 16441980
• Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.

  Razavi Z, Maher S, Fredmal J. Razavi Z, et al. Endocrine. 2018 Aug;61(2):267-274. doi: 10.1007/s12020-018-1635-z. Epub 2018 May 24. Endocrine. 2018. PMID: 29797212 Clinical Trial.
• Overview of the diagnosis and management of diabetic ketoacidosis.

  Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N. Eledrisi MS, et al. Am J Med Sci. 2006 May;331(5):243-51. doi: 10.1097/00000441-200605000-00002. Am J Med Sci. 2006. PMID: 16702793 Review.